1. Home
  2. LUNG vs CMCM Comparison

LUNG vs CMCM Comparison

Compare LUNG & CMCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • CMCM
  • Stock Information
  • Founded
  • LUNG 1995
  • CMCM 2009
  • Country
  • LUNG United States
  • CMCM China
  • Employees
  • LUNG N/A
  • CMCM N/A
  • Industry
  • LUNG Industrial Specialties
  • CMCM Computer Software: Prepackaged Software
  • Sector
  • LUNG Health Care
  • CMCM Technology
  • Exchange
  • LUNG Nasdaq
  • CMCM Nasdaq
  • Market Cap
  • LUNG 124.0M
  • CMCM 115.1M
  • IPO Year
  • LUNG 2020
  • CMCM 2014
  • Fundamental
  • Price
  • LUNG $2.78
  • CMCM $4.62
  • Analyst Decision
  • LUNG Buy
  • CMCM
  • Analyst Count
  • LUNG 6
  • CMCM 0
  • Target Price
  • LUNG $11.53
  • CMCM N/A
  • AVG Volume (30 Days)
  • LUNG 311.3K
  • CMCM 24.5K
  • Earning Date
  • LUNG 07-30-2025
  • CMCM 06-19-2025
  • Dividend Yield
  • LUNG N/A
  • CMCM N/A
  • EPS Growth
  • LUNG N/A
  • CMCM N/A
  • EPS
  • LUNG N/A
  • CMCM N/A
  • Revenue
  • LUNG $87,473,000.00
  • CMCM $120,663,543.00
  • Revenue This Year
  • LUNG $18.02
  • CMCM $14.27
  • Revenue Next Year
  • LUNG $18.17
  • CMCM $39.26
  • P/E Ratio
  • LUNG N/A
  • CMCM N/A
  • Revenue Growth
  • LUNG 19.84
  • CMCM 27.02
  • 52 Week Low
  • LUNG $2.50
  • CMCM $3.02
  • 52 Week High
  • LUNG $9.37
  • CMCM $6.77
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 41.83
  • CMCM 67.42
  • Support Level
  • LUNG $2.52
  • CMCM $4.53
  • Resistance Level
  • LUNG $2.84
  • CMCM $4.90
  • Average True Range (ATR)
  • LUNG 0.16
  • CMCM 0.19
  • MACD
  • LUNG 0.04
  • CMCM 0.05
  • Stochastic Oscillator
  • LUNG 46.36
  • CMCM 89.80

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About CMCM Cheetah Mobile Inc. each representing fifty (50)

Cheetah Mobile Inc along with its subsidiaries provides comprehensive products and services on PCs and mobile devices. It generates revenue from utility-related business, including advertising services and premium membership services. It also provides multi-cloud management platform and overseas advertising agency service. The company operates in two segments: Internet business, and AI and others. The firm's majority of the revenue is derived from the internet business segment that provides mobile advertising services to advertising customers, as well as selling advertisements and referring user traffic on its mobile and PC platforms. Geographically, it derives the majority of its revenue from the PRC and the rest from Hong Kong, Japan, and the rest of the world.

Share on Social Networks: